HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Gold Bond Bolstered With Three New Products Shipping In 2003

This article was originally published in The Rose Sheet

Executive Summary

Chattem is looking to three new Gold Bond line extensions to drive double-digit growth in the brand

Chattem is looking to three new Gold Bond line extensions to drive double-digit growth in the brand.

Gold Bond Antifungal Swabs for the treatment of athlete's foot, along with Gold Bond First Aid Antiseptic Wipes and Gold Bond First Aid Antiseptic Quick Spray to treat minor cuts, scrapes, insect bites and sunburns, will begin shipping in the first quarter of 2003, Chattem announced at a Banc of America Securities Conference in San Francisco, Sept. 26.

While recent additions to the line, including the launch of Gold Bond Foot Spray earlier this year, helped drive the brand's revenues up about 10% for the fiscal third quarter ended Aug. 31, Chattem predicts a more conservative increase of 5% to 6% for the year.

During a Sept. 27 analysts call, CEO Zan Guerry noted the new athlete's foot product employs the same "hands free" swab delivery system used in pHisoderm Clear Swab (1 (Also see "Chattem Phisoderm Clear Swabs Launch Will Target “Back-To-School” Crowd" - HBW Insight, 1 Apr, 2002.), p. 7).

In addition, Chattem has strengthened the brand by repackaging the Gold Bond Lotion "with a softer, rounded-shoulder bottle that gives it, we think, a little more appeal to women, who are the principal purchasers of lotions," President and Chief Operating Officer Alec Taylor said.

Chattem also will seek to expand international sales of its brands by exploiting markets where Selsun Blue medicated dandruff shampoo brand is strong.

The firm's contract with Abbott Labs, from which it purchased Selsun, states that by March 2004 all international distribution is to be turned over to Chattem, Taylor said.

The company has entered into multiple agreements for immediate Chattem-controlled distribution of Selsun Blue in Mexico, Australia, the Far East and South Africa. The agreements were drafted to allow Chattem "to springboard or piggyback other Chattem brands into those markets," Taylor said.

The firm will focus advertising in the UK, Italy and Canada, where Selsun has been "under marketed," Taylor said. Chattem is attempting to get a 1% selenium sulfide version of the shampoo approved for "general sales list" status in the UK; presently the dandruff shampoo is only available in "pharmacy" status in a 2.5% selenium sulfide formulation.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel